Call: 1-800-887-8100

 

New here?
Please register
Already a member?
Sign in now

 
Starting COPAXONE(R) Choosing a Therapy Importance of Therapy Therapy Expectations

Share Print
Copaxone Co-Pay Solutions No More Than $35 Per Month

Tricia C., on COPAXONE® since 1999.

Whether you’re already on COPAXONE® or just starting — now most people with insurance will pay no more than
$35 per month out of pocket

  • No financial qualifications required
  • If your insurance recently changed, give us a call
Your co-pay could be lower. Call Shared Solutions® today! 1-800-887-8100

Shared Solutions®
Helping you find the right financial solutions to help you start and stay on COPAXONE®

  • If COPAXONE Co-pay Solutions isn’t right for you, Shared Solutions® may still be able to help

Learn more about benefits & insurance
assistance here

Make a Smart Choice with COPAXONE®


Certain limits and restrictions apply.
Terms and Conditions: COPAXONE Co-pay Solutions is open to both new and existing patients who are residents of the US or Puerto Rico and who have private insurance coverage. The offer is not valid for patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void in Massachusetts or where otherwise prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance.
Current rating: 3.3 (22 ratings)
COP112012815/111542
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner

My recent articles

Article & Tip Submission

Benefits & Insurance Assistance

Injection Assistance

Social Relationships

master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.